There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Abstract
Postsurgical recurrence of hepatocellular carcinoma (HCC) is frequent and fatal. Adoptive
immunotherapy is active against HCC. We assessed whether postoperative immunotherapy
could lower the frequency of recurrence.